Tag: AVF
Inari Medical announces partnership with AVF and NBCA on DEFIANCE trial
In recognition of World Thrombosis Day, Inari Medical recently announced collaborative partnerships with the American Venous Forum (AVF) and the National Blood Clot Alliance...
VVT Medical receives endorsement letter from AVF on CPT coding guidance...
VVT Medical recently announced that the American Venous Forum (AVF) has provided an official opinion letter regarding CPT coding guidance for the ScleroSafe percutaneous...
Societies seek consensus on NIVL management amid “paucity of rigorous data”
The diagnosis and management of non-thrombotic iliac vein lesions (NIVL) is the focus of a newly published set of consensus statements from the Vascular...
Multi-society guidelines on varicose vein management published
The Society for Vascular Surgery (SVS), American Venous Forum (AVF), and American Vein and Lymphatic Society (AVLS) have released the second and final part...
“Excellent outcomes” for Zilver Vena® venous stent sustained out to three...
This advertorial is sponsored by Cook Medical. A downloadable version can be found here.
The Zilver Vena venous self-expanding stent system (Cook Medical) is associated...
Select gene single nucleotide polymorphisms found to be associated with venous...
Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous...
AVF 2022: Emerging autogenous venous valve formation system sees “continual improvement”
An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full...
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system (Inari Medical) in a real-world deep vein...
AVF 2022: VenoValve improvement “maintained” for 2.5 years without adverse events
Envveno Medical announced positive 30-month data from the first-in-human trial of the VenoValve bioprosthetic potential venous valve replacement during the 2022 American Venous Forum...
Results from first-in-human study of Amplifi vein dilation system presented at...
Preliminary clinical results from a first-in-human study assessing the Amplifi vein dilation system (Artio Medical) were presented at Vascular Interventional Advances (VIVA) 2021 (5–7 October...
Artio Medical completes enrolment of first-in-human trial investigating Amplifi vein dilation...
Artio Medical announced today it has completed enrolment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated...
Fist Assist device for focal arm massage and increased vein circulation...
Fist Assist Devices has received US Food and Drug Administration (FDA) 510(k) clearance for use of the Fist Assist FA-1 device in the USA...
AVF schedules education series for trainees, early-career practitioners
The American Venous Forum (AVF) is to stage a four-part series of educational sessions aimed at residents, fellows, and early-career practitioners in vascular surgery,...
2020 update to CEAP classification system and reporting standards published
A 2020 update on the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification system and reporting standards, authored by Fedor Lurie (Jobst Vascular Institute, Toledo, USA; University of Michigan,...
AVF releases white paper on considerations in prophylaxis and treatment of...
The COVID-19 subcommittee of the American Venous Forum (AVF) has issued a white paper on considerations in prophylaxis and treatment of venous thromboembolism (VTE)...
Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness
As a podium talk at the annual meeting of the American Venous Forum (VENOUS 2020; 3–6 March, Amelia Island, USA), it represented a bit...
C-TRACT trial on image-guided procedures for mitigating post-thrombotic syndrome partners with...
Writing to members of the American Venous Forum (AVF), president Brajesh K Lal (Baltimore, USA), has revealed that the AVF has established a partnership...
Study sees 42% of patients without post-thrombotic syndrome misclassified with Villalta...
The common diagnosis of post-thrombotic syndrome (PTS) includes a history of deep venous thrombosis and a Villalta Scale score of four or above. However, a...
Setting the record straight: Clarifying the misconceptions of the ATTRACT trial
A special session during the pre-conference Day of Innovation and Science at the American Venous Forum annual meeting (AVF; 20–23 February, Tucson, USA) presented...
High lysis completeness “guarantees high success rates” of iliac vein stent...
A recent study on iliac vein stenting following catheter-directed thrombolysis for deep vein thrombosis (DVT) has shown that technical and clinical success require high...